MedPath

Evaluation of heparin and hydro cortisone in prevention of thrombophlebitis.

Not Applicable
Conditions
Health Condition 1: I808- Phlebitis and thrombophlebitis ofother sites
Registration Number
CTRI/2023/04/051656
Lead Sponsor
ESIC MEDICAL COLLEGE AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Patients of either sex

2) Age18 to 65years

3) American society of anaesthesiologists (ASA) physical status I&II

Exclusion Criteria

1) Patient refusal

2) ASA Physical status III&IV

3) Pregnant women

4) Intellectually challengedpatients

5) Patientswitha known history of allergy to heparin

6) Patients undergoing general anesthesia

7) Patients on anticoagulantsor bleeding diasthesis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduction in incidence of thrombophlebitis by 50%Timepoint: 48 HOUR
Secondary Outcome Measures
NameTimeMethod
not applicableTimepoint: not applicable
© Copyright 2025. All Rights Reserved by MedPath